BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15610859)

  • 21. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R; Lörch T; Rudas M; Ambros PF
    Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of erbB-2 gene amplification in bladder cancer.
    Sauter G; Moch H; Moore D; Carroll P; Kerschmann R; Chew K; Mihatsch MJ; Gudat F; Waldman F
    Cancer Res; 1993 May; 53(10 Suppl):2199-203. PubMed ID: 8097962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarrays for gene amplification surveys in many different tumor types.
    Schraml P; Kononen J; Bubendorf L; Moch H; Bissig H; Nocito A; Mihatsch MJ; Kallioniemi OP; Sauter G
    Clin Cancer Res; 1999 Aug; 5(8):1966-75. PubMed ID: 10473073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
    Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C
    Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
    Sauter G; Moch H; Gudat F; Mihatsch MJ; Haley J; Meecker T; Waldman F
    Verh Dtsch Ges Pathol; 1993; 77():247-51. PubMed ID: 7511290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between aneuploidy of chromosome 17 and amplification of HER-2/neu gene in the different histological type of breast cancer].
    Kuroso K; Ueda Y; Mori Y
    Rinsho Byori; 2004 Nov; 52(11):897-9. PubMed ID: 15658468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance].
    Yang H; Zhang G; Xu K
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):367-70. PubMed ID: 10921034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amplification of C-erB-2 oncogene in colon carcinomas].
    Wang YP; Chen SQ; Xue KX
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):536-8, 582. PubMed ID: 7842350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a relationship between c-erbB-1 and c-erbB-2 amplification and protein overexpression in NSCLC?
    Meert AP; Martin B; Verdebout JM; Noël S; Ninane V; Sculier JP
    Lung Cancer; 2005 Mar; 47(3):325-36. PubMed ID: 15713516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
    Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
    Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
    Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
    Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of archival frozen tumor tissue imprint specimens for fluorescence in situ hybridization.
    Demetrick DJ
    Mod Pathol; 1996 Feb; 9(2):133-6. PubMed ID: 8657719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
    Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
    J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis.
    Fernández JL; Goyanes V; López-Fernández C; Buño I; Gosálvez J
    Cancer Genet Cytogenet; 1996 Jan; 86(1):18-21. PubMed ID: 8616779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and pathologic significance of 1p, 17p, and 18q aneusomy and the ERBB2 gene in colorectal cancer and related normal colonic mucosa.
    Cianciulli A; Cosimelli M; Marzano R; Merola R; Piperno G; Sperduti I; de la Iglesia F; Leonardo G; Graziano F; Mancini R; Guadagni F
    Cancer Genet Cytogenet; 2004 May; 151(1):52-9. PubMed ID: 15120910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.